Q3 2015 Holdings
Filed 2015-11-10 | 67 holdings | $16.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P 500 ETF TR(SPY) | TR UNIT | 78462F103 | $3.1K | 15,915 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $3.1K | 51,695 | 0.0% |
| Facebook Inc(META) | CL A | 30303M102 | $3.5K | 38,768 | 0.0% |
| Allergan PLC | SHS | G0177J108 | $3.7K | 13,483 | 0.0% |
| Novartis A G(NVSN) | SPONSORED ADR | 66987V109 | $3.8K | 40,810 | 0.0% |
| Mastercard Inc(MA) | CL A | 57636Q104 | $4.8K | 53,460 | 0.0% |
| Visa Inc(V) | COM CL A | 92826C839 | $4.9K | 69,858 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $4.9K | 35,685 | 0.0% |
| Nike Inc(NKE) | CL B | 654106103 | $5.0K | 40,907 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $5.0K | 51,285 | 0.0% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $5.3K | 10,410 | 0.0% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $5.9K | 69,950 | 0.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $612.0K | 7,617 | 3.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $2.8M | 26,130 | 17.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $3.4M | 11,804 | 21.5% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $3.6M | 65,375 | 22.2% |
| Adobe SYS Inc(ADBE) | COM | 00724F101 | $5.5M | 66,814 | 34.3% |